[
    "Table 1.Optimization of the electrochemical C\u2212H amination.[a] [a]\u2005Reaction conditions: Undivided cell, RVC anode, Pt cathode, constant current=4\u2005mA,1\u2009a(0.5\u2005mmol),2\u2009a(2.0\u2005equiv), catalyst (20\u2005mol\u2009%), NaOPiv (2.0\u2005equiv), AcOH (2.4\u2005equiv), CH3CN (10\u2005mL), 23\u2009\u00b0C, 18\u2005h. [b]\u2005Yield of isolated product. [c]\u2005No electricity. [d]\u2005AcOH (1.2\u2005equiv).",
    "Figure 1 Selected medicinally-relevant aminated azoles.",
    "Figure 2 Catalyst- and reagent-free electrochemical C\u2212H amination.",
    "Scheme 1 Preliminary electrochemical C\u2212H amination.",
    "Scheme 2 Catalyst-free electrochemical amination of azoles1. [a]1(0.5\u2005mmol),2\u2009a(2.0\u2005equiv), AcOH (2.4\u2005equiv), Zn(OAc)2(20\u2005mol\u2009%) in CH3CN at 60\u2009\u00b0C for 48\u2005h. [b]\u200580\u2009\u00b0C.",
    "Scheme 3 Electrochemical C\u2212H amination with amines2. [a]\u200560\u2009\u00b0C. [b]\u200580\u2009\u00b0C.",
    "Scheme 4 Synthesis of anti-HIV and antitumor piperazine4via electrochemical C\u2212H nitrogenation.",
    "Scheme 5 Summary of mechanistic findings.",
    "Scheme 6 Catalyst-free electrochemical C(sp3)\u2212H amination.",
    "Figure 3 (a)\u2005Cyclic voltammograms at 100\u2005mV\u2009s\u22121:nBu4NPF6(0.1min MeCN), concentration of substrates 4\u2005mm. (b)\u2005Cyclic voltammograms at 100\u2005mV\u2009s\u22121: Influence of AcOH and KOAc.",
    "Figure 4 In-operando kinetic ReactIR studies.",
    "Scheme 7 Proposed mechanism for catalyst-free C\u2212H amination."
]